CX3CR1 Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of CX3CR1 monoclonal antibodies for research focused on understanding this critical chemokine receptor. CX3CR1 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CX3CR1, also known as fractalkine receptor, plays a significant role in the immune response by mediating the adhesion and migration of immune cells to sites of inflammation. The receptor is involved in various physiological processes, including neuroinflammation and the regulation of monocyte trafficking. Understanding CX3CR1 function is crucial for elucidating its implications in diseases such as atherosclerosis, multiple sclerosis, and cancer. Research utilizing CX3CR1 monoclonal antibodies has revealed important insights into immune cell recruitment and inflammatory responses. Current investigations continue to uncover new roles for CX3CR1 in health and disease. Ongoing studies with CX3CR1 monoclonal antibodies are advancing our knowledge of cellular signaling pathways and potential therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of immune system regulation and disease mechanisms.